State KS
Clinical Trials in Kansas
Kansas is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Kansas and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 141 actively recruiting studies with Kansas sites out of 141 registered in total. The busiest research areas in Kansas are Breast Cancer, Cystic Fibrosis, Prostate Cancer. Leading sponsors running trials in the state include National Cancer Institute (NCI), University of Kansas Medical Center, AstraZeneca. By stage, Kansas trials break down as Phase 1 (22), Phase 2 (34), Phase 3 (46), Phase 4 (2).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Kansas
Frequently Asked Questions — Clinical Trials in Kansas
How many clinical trials are currently recruiting in Kansas?
ClinicalMetric currently tracks 141 actively recruiting clinical trials with at least one location in Kansas. The total number of registered studies—including active but not currently enrolling trials—is 141. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Kansas?
Kansas hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Cystic Fibrosis, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Kansas serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Kansas?
To join a clinical trial in Kansas, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Kansas maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Kansas
NCT06942949 N/A
Recruiting
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Ston...
Condition
Kidney Calculi; Ureteral Calculi
Enrollment
101 pts
Location
United States
Sponsor
Avvio Medical
NCT07652658 Phase 2
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Condition
Idiopathic Pulmonary Fibrosis (IPF)
Enrollment
359 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07330778 Phase 1
Recruiting
A Study of CDX-622 in Participants With Mild to Moderate Asthma
Condition
Mild to Moderate Asthma
Enrollment
12 pts
Location
United States
Sponsor
Celldex Therapeutics
NCT03489278 N/A
Recruiting
Clinical Procedures to Support Research in ALS
Condition
Amyotrophic Lateral Sclerosis
Enrollment
1,200 pts
Location
United States
Sponsor
University of Miami
NCT07195734 Phase 2
Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery...
Condition
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
Enrollment
180 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT05052606 N/A
Recruiting
Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry
Condition
Turner Syndrome
Enrollment
5,000 pts
Location
United States
Sponsor
University of Colorado, Denver
NCT07662044 Phase 3
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone o...
Condition
Type 2 Diabetes Mellitus
Enrollment
800 pts
Location
United States, Argentina, China
Sponsor
AstraZeneca
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Condition
Colorectal Cancer
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT00196742 N/A
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
Condition
Fabry Disease
Enrollment
9,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT06746883 N/A
Recruiting
A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam...
Condition
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Enrollment
100 pts
Location
United States
Sponsor
Innoviva Specialty Therapeutic
NCT03802851 N/A
Recruiting
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent...
Condition
Prostate Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07415031 Phase 2
Recruiting
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated ...
Condition
Solid Tumors
Enrollment
170 pts
Location
United States, Australia, Belgium
Sponsor
Mirati Therapeutics Inc.
NCT06877572 N/A
Recruiting
Weight Loss Management in Endometrial Cancer Survivors
Condition
Endometrial Cancer Survivors
Enrollment
50 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
900 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
NCT07702578 Phase 3
Recruiting
A Phase 3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoi...
Condition
AML
Enrollment
310 pts
Location
United States
Sponsor
TScan Therapeutics, Inc.
NCT06433947 Phase 1
Recruiting
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed an...
Condition
Relapsed Multiple Myeloma
Enrollment
130 pts
Location
United States
Sponsor
Opna Bio LLC
NCT07253285 Phase 3
Recruiting
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Ado...
Condition
Overweight
Enrollment
460 pts
Location
United States, Australia, Austria
Sponsor
Novo Nordisk A/S
NCT05896189 N/A
Recruiting
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Surv...
Condition
Breast Cancer
Enrollment
386 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
NCT06190717 N/A
Recruiting
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
Condition
Diabetes
Enrollment
304 pts
Location
United States
Sponsor
Sonavex, Inc.
NCT07321652 Phase 3
Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment ...
Condition
Chronic Lymphocytic Leukemia
Enrollment
466 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06961591 N/A
Recruiting
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectua...
Condition
Intellectual Disability
Enrollment
114 pts
Location
United States
Sponsor
University of Kansas Medical C
NCT07175038 Phase 2
Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pu...
Condition
Pulmonary Arterial Hypertension (PAH)
Enrollment
40 pts
Location
United States, Australia, Canada
Sponsor
AllRock Bio, Inc.
NCT06297226 Phase 2
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Ther...
Condition
Multiple Myeloma
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology